Skip to content

Impact of Air Pollution on Chronic Respiratory Diseases

The Impact of Air Pollution on Chronic Respiratory Diseases: a Prospective Cohort Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03813810
Enrollment
360
Registered
2019-01-23
Start date
2019-01-25
Completion date
2021-12-31
Last updated
2019-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis

Brief summary

The aim of this study is to evaluate the impact of air pollution on the occurrence and clinical course of chronic respiratory diseases, and discover new biomarkers from various devices such as CT images that can indicate the process and amount of lung damage caused by air pollution. Accordingly, the investigators have designed an prospective cohort with enrollment of normal people and patients with chronic respiratory diseases of three different categories (chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis). Participants will be followed up for a period of one year, with evaluation of the clinical course of the respiratory disease and exposure to air pollution.

Detailed description

Normal people (n=90) and patients with chronic respiratory diseases (chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, n=90 for each disease) will be enrolled at 5 different institutions in South Korea and followed up for one year. Inspiratory-expiratory CTs and tests including physical examination and blood/urine tests would be performed at the time of enrollment and the time at completion of the follow up period for each participant. Participants would be checked for the residency and working places, as well as checked for the amount of air pollution exposure using a wearable measurement device for 5 days during the study period ( time at enrollment / 3 months / 6 months / 9 months / time at completion). The device would cause no effect on usual daily life or the medical status of the participant. The clinical course such as occurrence of disease, acute exacerbation, decline of lung function, imaging status, mortality would be evaluated as well as the exposure of air pollution for each individual.

Interventions

OTHERNon

There would be no interventions. Only measurements will be performed.

Sponsors

Seoul National University Bundang Hospital
CollaboratorOTHER
SMG-SNU Boramae Medical Center
CollaboratorOTHER
National Medical Center, Seoul
CollaboratorOTHER
KangWon National University Hospital
CollaboratorOTHER
Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Normal: People with no lung lesions in chest X-ray and St. George's Respiratory Questionnaire score \<25, and post bronchodilator FEV1/FVC (forced expiratory volume at one second/forced vital capacity) \>= 0.7 and FEV1 \>= 80% and FVC \>= 80%. * Chronic obstructive pulmonary disease: Patients with over 10 pack-years of smoking history and post bronchodilator FEV1/FVC \<0.7 and FEV1 \< 80%, and no other reason for decline of lung function. * Asthma: Patients with FEV1/FVC \< 0.85 and increase in over 12% and 200mL of FEV1 by bronchodilator inhalation. Patients with P20 \< 16mg/dL by bronchial provocation test. * Idiopathic pulmonary fibrosis: Shows usual interstitial pneumonia according to chest CT and has no other reasons such as systematic diseases or medication history.

Exclusion criteria

* Subjects who refused for enrollment in the study * Subjects who experienced an acute exacerbation within 1 month. * Subjects under age of 19.

Design outcomes

Primary

MeasureTime frameDescription
Rate of mortalityan average of 1 yearEvents of mortality through study completion
Rate of acute exacerbationsan average of 1 yearEvents of acute exacerbations through study completion
Change of disease extent in CT imagingan average of 1 yearEmphysema index (0-100, higher values representing worse outcome)
Change in lung functionan average of 1 yearFEV1 (forced expiratory volume at one second, 10-150 %, lower values representing worse outcome)
Change in symptom scoran average of 1 yearSt. George's Respiratory Questionnaire score (0-100, higher values representing worse outcome)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026